-

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 November 2025

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News:

Eurofins Scientific SE (Paris:ERF):

ANNEXE B

Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on transparency requirements for issuers of securities

  1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedi (including the issuer ID allocated by the CSSF
    EUROFINS SCIENTIFIC SE – E1013
  2. Identity of the notifier (if another person makes the notification on behalf of the issuer) N/A
  3. Total number of shares composing the share capital of the notifying issuer
    182,163,000
  4. Total number of voting rights attached to the shares composing the share capital of the notifying issuer, including the suspended voting rightsii
    366,664,553
  5. Origin of the changeiii
    • Cancellation of some class A beneficiary units
    • Purchase of treasury shares
  6. Date when the change occurred
    30 November 2025

i Either the full name of the legal entity or another method for identifying the issuer or underlying issuer, provided it is reliable and accurate.
ii For further details on the total number of voting rights, please refer to point 1(b) of circular CSSF 08/349.
iii As, for example, a capital increase or reduction.

Contacts

Eurofins Scientific SE

Eurofins Scientific SE

BOURSE:ERF
Release Versions
English

Contacts

Eurofins Scientific SE

More News From Eurofins Scientific SE

Eurofins CDMO Alphora Joins International Consortium Project to Advance Next Generation ADC Expression Platform

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Eurofins CDMO Alphora is pleased to announce that its Canadian-based division is receiving advisory services and funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support a research and development collaboration project focused on advancing a transformative approach for next-generation ADC (antibody-drug conjugate) production to meet the growing demand for targeted therapeutics. As part of this initia...

Eurofins MET Laboratories Opens New Safety, EMC, Wireless, and Renewable Energy Laboratory in the Boston Tech Corridor

BOSTON--(BUSINESS WIRE)--Eurofins MET Laboratories, part of the Eurofins Electrical & Electronics global network, announces the opening of its new state-of-the-art 60,000-square-foot testing laboratory in Littleton, Massachusetts – a prime location in the Boston innovation corridor. Positioned at the epicenter of New England's med-tech, wireless innovation, clean energy, and advanced electronics ecosystem, the capabilities of this laboratory further position Eurofins MET Laboratories as the...

Eurofins Scientific SE: Weekly Report on Share Repurchases from 26th January to 30th January 2026

LUXEMBOURG--(BUSINESS WIRE)--Regulatory News: Eurofins Scientific SE (Paris:ERF): Name of the Issuer Identify code of the Issuer Transaction day Identify code of the financial instrument Total daily volume (in number of shares) Daily weighted average purchase price of the shares Market (MIC Code) EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 26/01/2026 FR0014000MR3 5 000 70.7336 XPAR EUROFINS SCIENTIFIC 529900JEHFM47DYY3S57 27/01/2026 FR0014000MR3 5 000 70.9680 XPAR EUROFINS SCIENTIFIC 529900JEHFM47...
Back to Newsroom